ViennaLab Diagnostics is a privately held company established in Vienna, Austria. The original founders, Fritz Kury and Robert Zeilinger, gave ViennaLab Diagnostics a human but also very scientific impulse, which has been firmly integrated into the DNA of the company. In 2020, ViennaLab became a full member of the BioVendor Group family.

Our focus is on product development, promoting original IVD StripAssays^®, RealFast™ and NGS assays with an international network of distribution partners.

ViennaLab products offer differentiated options, presenting customized solutions for genetic testing. From simple and rapid single marker detection to complex genetic analysis.

Our kits are CE/IVD labeled  - some of them already successfully passed IVDR certification - and our QM system, assessed by the TÜV Süd Notified Body, is in compliance with the EN ISO 13485 standard - download  pdf ISO certificate - and with the requirements according to the IVDR 2017/746 (EU) - download pdf IVDR certificate.

About BioVendor Group

We are an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, we have grown from a local company into a global innovator with in-house research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network.

Our strategy is anchored by three key projects – CLIA, MBA, and NGS – focusing our innovation and delivery across next-generation sequencing, chemiluminescent immunoassays, and Microblot-Array. By combining scientific excellence, strong innovation capacity, and a presence in more than 100 markets worldwide, we deliver solutions that advance laboratory practice and patient care, making us one of the key players in clinical diagnostics.